Evidence map›Paper›PMID 16670773›Full record

ArticleThe Journal of clinical investigation2006

Airway smooth muscle prostaglandin-EP1 receptors directly modulate beta2-adrenergic receptors within a unique heterodimeric complex.

Dennis W McGraw, Kathryn A Mihlbachler, Mary Rose Schwarb, Fahema F Rahman, Kersten M Small, Khalid F Almoosa, Stephen B Liggett

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Trial
  2. Article
  3. GPCR Heterodimers: Implications for Biased Signaling.Handbook of experimental pharmacology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. G Protein-Coupled Receptor Heteromers.Annual review of pharmacology and toxicology · 2016
    Review
  13. Article
  14. Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  15. Article
  16. Bitter taste receptor function in asthmatic and nonasthmatic human airway smooth muscle cells.American journal of respiratory cell and molecular biology · 2014
    Article
  17. Article
  18. Review
  19. Article
  20. cAMP regulation of airway smooth muscle function.Pulmonary pharmacology & therapeutics · 2013
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Dennis W McGrawDepartment of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Kathryn A Mihlbachler
Mary Rose Schwarb
Fahema F Rahman
Kersten M Small
Khalid F Almoosa
Stephen B Liggett

Funding

Basis of Variability of Lung GPCR SignalingR01HL071609 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI LIGGETT, STEPHEN B · 2003 to 2013
$3.7M
Molecular properties of B-adrenergic receptors in AsthmaR37HL045967 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI LIGGETT, STEPHEN B · 2002 to 2012
$3.2M
MOLECULAR PROPERTIES OF B-ADRENERGIC RECEPTORS IN ASTHMAR01HL045967 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI LIGGETT, STEPHEN B · 1990 to 2018
$1.3M
Molecular properties of B-adrenergic receptors in AsthmaR56HL045967 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI LIGGETT, STEPHEN B · 2015 to 2015
$374k
NHLBI NIH HHS HL045967NHLBI NIH HHS HL071609NHLBI NIH HHS R01 HL045967NHLBI NIH HHS R01 HL071609NHLBI NIH HHS R37 HL045967NHLBI NIH HHS R56 HL045967
6 · The paper itself

Abstract

Multiple and paradoxical effects of airway smooth muscle (ASM) 7-transmembrane-spanning receptors activated during asthma, or by treatment with bronchodilators such as beta(2)-adrenergic receptor (beta(2)AR) agonists, indicate extensive receptor crosstalk. We examined the signaling of the prostanoid-EP(1) receptor, since its endogenous agonist prostaglandin E(2) is abundant in the airway, but its functional implications are poorly defined. Activation of EP(1) failed to elicit ASM contraction in mouse trachea via this G(alphaq)-coupled receptor. However, EP(1) activation markedly reduced the bronchodilatory function of beta(2)AR agonist, but not forskolin, indicating an early pathway interaction. Activation of EP(1) reduced beta(2)AR-stimulated cAMP in ASM but did not promote or augment beta(2)AR phosphorylation or alter beta(2)AR trafficking. Bioluminescence resonant energy transfer showed EP(1) and beta(2)AR formed heterodimers, which were further modified by EP(1) agonist. In cell membrane [(35)S]GTPgammaS binding studies, the presence of the EP(1) component of the dimer uncoupled beta(2)AR from G(alphas), an effect accentuated by EP(1) agonist activation. Thus alone, EP(1) does not appear to have a significant direct effect on airway tone but acts as a modulator of the beta(2)AR, altering G(alphas) coupling via steric interactions imposed by the EP(1):beta(2)AR heterodimeric signaling complex and ultimately affecting beta(2)AR-mediated bronchial relaxation. This mechanism may contribute to beta-agonist resistance found in asthma.

Indexed as

AnimalsCell LineChlorocebus aethiopsColforsinCOS CellsDimerizationGuanosine 5'-O-(3-Thiotriphosphate)HumansMiceMuscle, SmoothReceptors, Adrenergic, beta-2Receptors, Prostaglandin EReceptors, Prostaglandin E, EP1 SubtypeSignal TransductionTracheaColforsinGuanosine 5'-O-(3-Thiotriphosphate)PTGER1 protein, humanPtger1 protein, mouseReceptors, Adrenergic, beta-2Receptors, Prostaglandin EReceptors, Prostaglandin E, EP1 Subtype

Identifiers

PMID16670773
PMCPMC1451203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.